HU215434B - Eljárás interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, vektorok és gazdasejtek előállítására - Google Patents

Eljárás interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, vektorok és gazdasejtek előállítására Download PDF

Info

Publication number
HU215434B
HU215434B HU3412/89A HU341289A HU215434B HU 215434 B HU215434 B HU 215434B HU 3412/89 A HU3412/89 A HU 3412/89A HU 341289 A HU341289 A HU 341289A HU 215434 B HU215434 B HU 215434B
Authority
HU
Hungary
Prior art keywords
sequence
priority
dna
inhibitor
amino acid
Prior art date
Application number
HU3412/89A
Other languages
English (en)
Hungarian (hu)
Other versions
HU893412D0 (en
Inventor
William P. Arend
Stephen P. Eisenberg
Charles H. Hannum
Fenneke G. Joslin
Andreas Sommer
Robert C. Thompson
Original Assignee
Synergen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc. filed Critical Synergen Inc.
Priority to HU9803037A priority Critical patent/HU9803037D0/hu
Publication of HU893412D0 publication Critical patent/HU893412D0/hu
Publication of HU215434B publication Critical patent/HU215434B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU3412/89A 1988-05-27 1989-05-25 Eljárás interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, vektorok és gazdasejtek előállítására HU215434B (hu)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9803037A HU9803037D0 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03

Publications (2)

Publication Number Publication Date
HU893412D0 HU893412D0 (en) 1991-05-28
HU215434B true HU215434B (hu) 1999-04-28

Family

ID=27394086

Family Applications (3)

Application Number Title Priority Date Filing Date
HU3412/89A HU215434B (hu) 1988-05-27 1989-05-25 Eljárás interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, vektorok és gazdasejtek előállítására
HU9803037A HU222810B1 (hu) 1988-05-27 1989-05-25 Interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, a szekvenciákat tartalmazó rekombináns DNS-vektorok, a vektort tartalmazó gazdasejtek és rekombináns GT-10-il-1i-2A DNS molekula
HU9803037A HU9803037D0 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU9803037A HU222810B1 (hu) 1988-05-27 1989-05-25 Interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, a szekvenciákat tartalmazó rekombináns DNS-vektorok, a vektort tartalmazó gazdasejtek és rekombináns GT-10-il-1i-2A DNS molekula
HU9803037A HU9803037D0 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Country Status (9)

Country Link
JP (2) JP3192651B2 (fi)
KR (1) KR970002917B1 (fi)
BR (1) BR8907457A (fi)
DK (1) DK172763B1 (fi)
FI (2) FI109206B (fi)
HU (3) HU215434B (fi)
NO (2) NO316122B1 (fi)
OA (1) OA09631A (fi)
WO (1) WO1989011540A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
CA2081774A1 (en) * 1990-05-01 1991-11-02 John Stephen Haskill Interleukin-1 antagonist and uses thereof
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5824549A (en) * 1990-10-09 1998-10-20 Chiron Corporation Transformed human T cell
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP1442132A2 (en) * 2001-10-26 2004-08-04 Novartis AG Methods for the treatment of osteoarthritis and compositions thereof
AU2003243139B2 (en) 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
EP2336177A1 (en) 2004-08-04 2011-06-22 Amgen, Inc Antibodies to DKK-1
JP5718640B2 (ja) 2007-08-21 2015-05-13 アムジエン・インコーポレーテツド ヒトｃ−ｆｍｓ抗原結合性タンパク質
CN102209557A (zh) * 2008-09-12 2011-10-05 埃克斯生物科技公司 靶向病原性单核细胞
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
US9359405B2 (en) 2011-03-14 2016-06-07 Phlogo Aps Antagonists of the interleukin-1 receptor
US20140308294A1 (en) 2011-04-15 2014-10-16 Merck Patent Gmbh Anti-IL-1R1 Inhibitors For Use in Cancer
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
WO2017156058A1 (en) 2016-03-08 2017-09-14 Janssen Biotech, Inc. Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8820676A (nl) * 1987-08-26 1989-07-03 Biogen Inc Biologische materialen, werkwijzen ter bereiding van biologische materialen en de toepassing van dergelijke materialen in therapie.

Also Published As

Publication number Publication date
WO1989011540A1 (en) 1989-11-30
NO20014783D0 (no) 2001-10-01
NO20014783L (no) 1991-01-28
FI905812A0 (fi) 1990-11-26
BR8907457A (pt) 1991-04-02
NO316917B1 (no) 2004-06-21
HU9803037D0 (en) 1999-11-29
AU633831B2 (en) 1993-02-11
AU3746989A (en) 1989-12-12
OA09631A (en) 1993-04-30
NO905090D0 (no) 1990-11-23
FI20020545A (fi) 2002-03-21
DK8591D0 (da) 1991-01-18
JPH03505279A (ja) 1991-11-21
KR970002917B1 (ko) 1997-03-12
FI109206B (fi) 2002-06-14
DK8591A (da) 1991-01-18
JP3192651B2 (ja) 2001-07-30
HU222810B1 (hu) 2003-11-28
NO316122B1 (no) 2003-12-15
NO905090L (no) 1991-01-28
HU893412D0 (en) 1991-05-28
JP2001029093A (ja) 2001-02-06
DK172763B1 (da) 1999-07-05

Similar Documents

Publication Publication Date Title
US5075222A (en) Interleukin-1 inhibitors
EP0541920B1 (en) Interleukin-1 inhibitors
KR100230156B1 (ko) 종양괴사인자 억제제 및 그 제조방법
HU215434B (hu) Eljárás interleukin-1 inhibitorok, ezeket kódoló DNS-szekvenciák, vektorok és gazdasejtek előállítására
US5141856A (en) Expression of purified ciliary neurotrophic factor
IE61146B1 (en) Amphiregulin glycoprotein exhibiting bifunctional cell growth regulatory activity
US5731167A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
US6143866A (en) Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
Shuck et al. Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein
RU2286388C2 (ru) Ингибитор интерлейкина-1, способ его получения, молекула днк, кодирующая ингибитор интерлейкина-1 и его предшественник
AU633831C (en) Interleukin-1 inhibitors
IE20030600A1 (en) Interleukin-1 inhibitors
PL164003B1 (pl) Sposób wytwarzania inhibitorów interleukiny-1 PL
IE83721B1 (en) Interleukin-1 inhibitors
IE19950317A1 (en) Interleukin-1 inhibitors

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: AMGEN INC., US